
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Long-term Results of a Phase 2 Trial of Nilotinib 400 Mg Twice Daily in Newly Diagnosed Patients with Chronic Phase of Chronic Myeloid Leukemia
Comments 0
Login to view comments.
Click here to Login